SCHEMBL12936668

SCHEMBL12936668

CC(C)(O)c1ccc2c(c1)/C(=C/CCN1CCCCC1)C1=CCCN=C1CO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.43
▸ HRH1 P35367 5/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32
▸ ADRA1B P35368 1/20 0.32
▸ PSMB1 P20618 1/20 0.31
▸ PSMB5 P28074 1/20 0.31
▸ PSMB2 P49721 1/20 0.31
▸ SIGMAR1 Q99720 2/20 0.30
▸ KCNK2 O95069 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12121948 0.76 CCR1 (0.68) CCR1HRH1HRH3ADRA1DADRA1A
SCHEMBL16312668 0.73 CCR1 (0.39) CCR1HRH1HRH3ADRA1DADRA1A
SCHEMBL15478321 0.73 CCR1 (0.43) CCR1HRH1HRH3ADRA1DADRA1A
SCHEMBL18633833 0.72 CCR1 (0.42) CCR1HRH1HRH3ADRA1DADRA1A
SCHEMBL18633827 0.69 CCR1 (0.39) CCR1HRH1HRH3SIGMAR1KCNK2
SCHEMBL18633830 0.68 CCR1 (0.37) CCR1HRH1HRH3PSMB1PSMB5
SCHEMBL15478357 0.67 CCR1 (0.63) CCR1HRH1ADRA1DADRA1AADRA1B
SCHEMBL13824458 0.67 CCR1 (0.37) CCR1HRH1HRH3
SCHEMBL16312649 0.66 CCR1 (0.62) CCR1HRH1ADRA1DADRA1AADRA1B
SCHEMBL15478326 0.66 CCR1 (0.58) CCR1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2286811-A1 Chemokine receptor antagonists and methods of use thereof Millennium Pharmaceuticals, Inc. (US) 2011-02-23 — — EP disclosed
Send feedback